UChicago Medicine begins clinical trial to explore convalescent plasma transfusions for COVID-19 patients
The University of Chicago Medicine is launching a clinical trial to study whether blood plasma from people who have recovered from COVID-19 can be used to treat patients who are still in the hospital with severe disease symptoms.
